Hormone Optimization
TRT, thyroid, and growth-hormone protocols with structured baseline testing.
About this treatment area
Hormone optimization clinics address testosterone deficiency, thyroid dysfunction, and age-related decline in growth hormone. Legitimate programs begin with comprehensive lab panels and only prescribe when clinically indicated. Growth hormone secretagogues (sermorelin, ipamorelin, CJC-1295) stimulate your body’s own GH production rather than replacing it.
Relevant peptides
Regulatory status as of September 2026. Always confirm with your provider.
Sermorelin
Compoundable
GHRH analogue. Formerly FDA-approved as Geref. Available via compounding. WADA-banned in sport.
CJC-1295 / Ipamorelin
Compoundable
GH secretagogue stack. Most common GH-optimization protocol. Compounding status shifted in 2026.
Tesamorelin
FDA-approved
FDA-approved as Egrifta for HIV lipodystrophy. Used off-label for visceral fat.
Testosterone
FDA-approved
FDA-approved for hypogonadism. Requires documented low levels on two morning draws.
Kisspeptin
Research only
Stimulates natural testosterone via GnRH. Investigational.
MK-677
Research only
Oral GH secretagogue. Not a peptide. Not approved. Banned in sport.